Oxford Nanopore Technologies Ltd
Research Oxford Nanopore Technologies Ltd (ONT) on Bullrun: market cap GBX 174.68B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerONT
- ExchangeLSE
- CountryUnited Kingdom
- SectorHealthcare
- IndustryBiotechnology
- CurrencyGBX
- Market capGBX 174.68B
- Financial periodFY2025
- RevenueGBP 223.90M
- Revenue growth22.2%
- Net income-GBP 145.20M
- Free cash flow-GBP 116.30M
- Gross margin58.6%
Valuation Snapshot
latest market cap is GBX 174.68B.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | GBP 223.90M | -GBP 145.20M | -GBP 116.30M | 58.6% | -0.15 | GBP 181.10M | GBP 41.50M | GBP 463.30M |
| FY2024 | GBP 183.19M | -GBP 146.19M | -GBP 158.52M | 57.5% | -0.16 | GBP 199.52M | GBP 45.96M | GBP 586.34M |
| FY2023 | GBP 169.67M | -GBP 154.51M | -GBP 164.59M | 53.3% | -0.19 | GBP 220.54M | GBP 41.66M | GBP 643.85M |
| FY2022 | GBP 198.60M | -GBP 91.03M | -GBP 91.62M | 62.3% | -0.11 | GBP 356.78M | GBP 34.10M | GBP 693.56M |
| FY2021 | GBP 133.66M | -GBP 167.61M | -GBP 84.02M | 54.8% | n/a | GBP 487.84M | GBP 24.80M | GBP 703.98M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-28 | GBX 174.68B | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 GBX.
About Oxford Nanopore Technologies Ltd
Oxford Nanopore Technologies plc engages in the research, development, manufacture, and commercialization of a novel generation of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) sequencing technology that allows analysis of DNA or RNA. The company offers MinION Mk 1D, a portable device for DNA and RNA sequencing; and GridION and GridION Q, a compact bench top device that delivers a version of hardware, software, and chemistry.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Oxford Nanopore Technologies Ltd's market cap?
Oxford Nanopore Technologies Ltd's market capitalization is GBX 174.68B.
What does Oxford Nanopore Technologies Ltd do?
Oxford Nanopore Technologies plc engages in the research, development, manufacture, and commercialization of a novel generation of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) sequencing technology that allows analysis of DNA or RNA. The company offers MinION Mk 1D, a portable device for DNA and RNA sequencing; and GridION and GridION Q, a compact bench top device that delivers a version of hardware, software, and chemistry. It also provides PromethION products, such as PromethION 2, PromethION 24, and PromethION 48.